24th Mar, 2015–Invited by Professor Kui Wang and Dr. Siwang Yu, Dr. Tony Ah-Ng Kong from Rutgers, the State University of New Jersey visited Peking University School of Pharmaceutical Sciences and presented in a series of academic activities.
Dr. Kong, the Glaxo Endowed Chair and Distinguished Professor of Pharmacy at the Ernest Mario School of Pharmacy, was honored as guest professor of Peking University Health Science Center in 2011. Currently he is the Director of Graduate Program in Pharmaceutical Sciences, also the Leader of Carcinogenesis and Chemoprevention Research Program of the Cancer Institute of New Jersey, and has continued serving on the NIH Study Sections since 1998. He also served as member of 13 editorial boards of international journals, editor of Pharmaceutical Research, the Editor-in-Chief of Current Pharmacology Reports, and the oversea editor of Journal of Chinese Pharmaceutical Sciences (JCPS). To the date, Dr. Kong has published more than 200 scientific articles with over 11000 citations. His current research interests are predominately in the areas of biology-driven natural product drug discovery and development, with primary emphasis in the fields of cancer chemoprevention.
During his visit to the JCPS editorial office, Dr. Kong met Associate Professor Heqing Huang, theExecutive Associate Editor-in-Chief of JCPS, and Drs. Jian Han and Jingjing Zhang, and discussed the up-coming JCPS special issues on “Cancer Prevention by Natural & TCM Products”. A tentative agreement of collaboration on international propagation was also reached.
Dr. Kong delivered a seminar entitled “Cancer Prevention by Natural & TCM Products: Nrf2 and Epigenetics”. Started from the successes and failures of cancer chemopreventive drugs, Dr. Kong introduced the current research progresses and perspectives of natural products and traditional Chinese medicine in cancer prevention, especially the involvement of redox signaling and epigenetic mechanisms. His talk sparked extensive interests and hot discussions among audience.